SwedenBIO har inlett en ny kartläggning av Sveriges läkemedelspipeline för att följa dess utveckling och stärka synligheten av svensk läkemedelsinnovation på den globala arenan.
Svensk life science är en sektor med enorm potential, men vi missar miljardinvesteringar, menar SwedenBIO i en färsk debattartikel.
SwedenBIO and Biocom California have signed a memorandum of understanding to undertake cooperative activities.
One of Sweden's most ambitious research initiatives to date aims to position the country as a global leader in data-driven life science.
SwedenBIOs vd Jessica Martinsson ger sin syn på regeringens nya forsknings- och innovationsproposition som presenterades nyligen.
Vicore Pharma, the winner of the SwedenBIO Award 2024 is praised for being at the forefront of addressing unmet medical needs in rare diseases and for securing one of Sweden’s largest biotech raises in 2024. Vicore's CEO, Ahmed Mousa, received the award in a prize ceremony during SwedenBIO Summit at Grand Hôtel in Stockholm on 11th December.
SwedenBIO, together with our partners, has prepared a smargosboard of benefits for Swedish companies attending JP Morgan week in San Fransisco.
Svar från 207 företag målar upp bilden av en dynamisk bransch med framtidshopp som skapar stora värden, men även oro kring den ständiga kampen om finansiering.
Pelago Bioscience, Xbrane Biopharma and Vicore Pharma are the finalists for the SwedenBIO Award 2024.
The international event brings together researchers, entrepreneurs and technologists from around the world to solve some of the most pressing health challenges.
